BusinessOtonomy Holds Investor and Analyst Day and Provides Corporate UpdateBy Nasdaq OMXOct 7, 2016, 12:00 PM UTC
BusinessOtonomy Announces Publication of OTIPRIO™ Phase 3 Clinical Trial Results in JAMA OtolaryngologyBy Nasdaq OMXMar 18, 2016, 11:30 AM UTC
